As immunotherapies pick up steam in the clinic, more researchers are turning to immune-modulation methods to solve long-standing challenges. At the center of the immune system's response to cancer are T cells. Find out how T cells could provide new solutions in the face of cancer's ever-evolving attacks. Will chimeric antigen receptor-expressing T cells lead the drive to cancer eradication? beckman.com/resources
Beckman Coulter: CAR-T Cells 101
Immunotherapy's key effector cells
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
